Abstract
Abl kinase plays a decisive role in the mechanism of the most fatal human pathogen chronic mylogenous leukemia (CML). Here, we have carried out a comprehensive study about the conformational flexibility, role of salt bridge and the protein- ligand interaction for this kinase with its well-known inhibitor, Imatinib. We have performed molecular dynamics simulations for conformational behavior, investigated the salt bridges and calculated the binding free energy of Imatinib with MM-PB/SA method for Abl kinase complex. We also explored the role of salt-bridge in the kinase complex and its effect on binding activity of inhibitors. Furthermore, to investigate the importance of those residues which form salt bridges, we mutated them by Alanine with the help of Alanine scanning program. We noticed significant variations in total free energy of Imatinib in all possible mutations. The binding free energy of ligand for kinase receptor was analyzed by molecular mechanics Poission Boltzmann surface area (MM-PB/SA) method. These results suggest that conserved glutamic acid and lysine are necessary for stability of complex.
Similar content being viewed by others
References
Rix U, Hantschel O, Durnberger G, Rix LLR, Planyavsky M, Fernbach NV, Kaupe I, Bennett KL, Valent P, Colinge J, Kocher T, Furga GS (2007) Chemical proteomic profiles of the BCR-ABL inhibitors Imatinib, Nilotinib and Dasatinib reveals novel kinases and non kinases targets. Blood 110:4055–4063
Seeliger MA, Nagar B, Frank F, Cao X, Henderson MN, Kuriyan J (2007) c-Src binds to the cancer drug imatinib with an inactive abl/c-kit conformation and a distributed thermodynamic penalty. Structure 15:299–311
Deininger MWN, GoldmanJM MJV (2000) The molecular Biology of chronic myeloid leukemia. Blood 96:3343–3356
Goodsell DS (2005) The molecular Biology of chronic myeloid leukemia. Oncologist 10:758–759
Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, Clarkson B, Superti-Furga G, Kuriyan J (2003) Structural basis for the auto inhibition of c-Abl tyrosine kinase. Cell 112:859–871
Nagar B (2007) c – Abl Tyrosine Kinase and inhibition by the cancer Drug Imatinib. J Nutr 137:1518S–1523S
Li W, Miller WT (2006) Role of activation loop tyrosine in regulation of the insulin-like growth factor I receptor tyrosine kinase. J Bio Chem 281:23785–23791
Emrick MA, Lee T, Starkey PJ, Mumby MC, Resing KA, Ahn NG (2006) The gatekeeper residue controls, auto activation of ERK2 via a pathway of intramolecular connectivity. PNAS 103:18101–18106
Shan Y, Seelinger MA, Eastwood MP, Frank F, Xu H, Jensen MO, Dror RO, Kuriyan J, Shaw DE (2009) A conserved protonation dependent switch controls drug binding in the Abl kinase. PNAS 106:139–144
Buettner R, Mesa T, Vulture A, Lee F, Jove R (2008) Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells. Mol Cancer Res 6:1766–1774
Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, Croci V, Degrassi A, Texido G, Rocchetti M, Vianello P, Rusconi L, Storici P, Zugnoni P, Arrigoni C, Soncini C, Alli C, Patton V, Marsiglio A, Ballinari D, Pesenti E, Fancelli D (2007) PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer. J Mol Cancer Res 6:3158–3168
Mol CD, Dougan DR, Schneider TR, Skene RJ, Kraus ML, Scheibe DN, Snell GP, Zou H, Sang BC, Wilson KP (2004) Structural basis for the auto inhibition and STI-571 inhibition of c-Kit tyrosine kinase. J Biol Chem 279:31655–31663
Nagar B, Bornmann W, Pellicena P, Schindler T, Veach D, Miller WT, Clarkson B, Kuriyan J (2002) Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and Imatinib (STI-571). Cancer Res 62:4236–4243
Cowan-Jacob SW, Fendrich J, Floersheimer A, Furel P, Liebentanz J, Rummel G, Rheinberger P, Centeleghe M, Fabbro D, Manely PW (2007) Structural bilogy contribution to the discovery of drug to treat chronic myelogenous leukaemia. Acta Cryst D 63:80–93
Tokarski JS, Newitt JA, Chang CHYJ, Cheng JD, Wittekind M, Kiefer SE, Kish K, Lee FYF, Brozillerri R, Lombardo LJ, Xie D, Zhang Y, Klei HE (2006) The structure of dasatinib (BMS-354825) bound to activated Abl kinase domain elucidates its inhibitory activity against Imatinib resistance Abl-Mutant. Cancer research 66:5790–5797
Denisov VP, Halle B (1996) Protein hydration dynamics in aqueous solution. Faraday Disc 103:227–244
Bryant RG (1996) The dynamics of water-protein interactions. Annu Rev Biophys Biomol Struct 25:29–53
Rupley JA, Careri G (1991) Protein hydration and function. Adv Protein Chem 41:37–172
Meyer E (1992) Internal water molecules and h-bonding in biological macromolecules: a review of structural features with functional implications. Protein Sci 1:1543–1562
Case DA, Cheatham TE, Daren T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The amber biomolecular simulation programs. J Comput Chem 26:1668–1688
Bayly CI, Cieplak P, Cornell W, Kollman PA (1993) A well behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem 97:10269–10280
Cornell WD, Cieplak P, Bayly CI, Kollman PA (1993) Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation. J Am Chem Soc 115:9620–9631
Jorgenson WL, Chandrashekhar J, Madura JD, Imprey RW, Klein M (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
Izaguirre JA, Catarello DP, Wozanaik JM, Skeel RD (2001) Langevin stabilization of molecular dynamics. J Chem Phys 114:2090–2098
Berendsen HJC, Postama JPM, van-Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690
Ryckaert JP, Cicotti G, Barendsen HJC (1977) Numerical integration of the Cartesian equation of motion of a system with constraints: Molecular dynamics of n-alkanes. J Comput Phys 23:327–341
Humphrey W, Dalke A, Schulten K (1996) VMD – virtual molecular dynamics. J Mol Graph Model 14:33–38
Pettersen EF, Goddard TD, Haung CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera – A visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
Maestro, Schrodinger Inc, USA (2008)
Gohlke H, Case DA (2003) Converging free energy estimates: MM-PB (GB) SA studies on the Protein-Protein Complex Ras-Raf. J Comput Chem 25:238–250
Fogolari F, Brigo A, Molinari H (2003) Protocols for MM/PBSA molecular dynamics simulations of proteins. Biophys J 85:159–166
Grochowaski P, Trylska J (2007) Continuum molecular electrostatics, salt effects, and counterion binding- a review of the poisson-boltzmann theory and its modifications. Biopolymers 89:93–113
Tsui V, Case DA (2001) Theory and application of generalized born solvation model in macromolecular simulations. Biopolymers 56:271–291
Dubey KD, Ojha RP (2011) Binding free energy calculation with QM/MM hybrid methods for Abl-Kinase inhibitor. J Biol Phys 37:69–78
Leach AR (2003) Molecular Modeling: Principle and Application, 2nd edn. Prentice Hall
Moreira IS, Fernandes PA, Ramos MJ (2006) Unraveling the importance of protein-protein interaction: application of computational alanine-mutagenesis to the study of the IgG1 streptococcal protein G (C2 fragment) complex. J Phys Chem B 110:10962–10969
Moreira IS, Fernandes PA, Ramos MJ (2006) Computational alanine scanning mutagenesis, an improved methodological approach. J Comput Chem 28:644–654
Masso M, Lu Z, Vaismann II (2006) Computational mutagenesis of protein structure function correlation. Proteins 64:234–245
Naim M, Bhat S, Rankin KN, Dennis S, Chowdhury SF, Siddiqi I, Drabik P, Sulea T, Bayly C, Jakalian A, Purisima EO (2007) Solvated interaction energy (SIE) for scoring protein ligand binding affinities. 1. Exploring the parameter space. J Chem Inf Model 47:122–133
Cui Q, Sulea T, Schrag JD, Munger C, Hung MN, Naim M, Cygler M, Purisima EO (2008) Molecular dynamics and solvated interaction energy studies of protein –protein interaction: The MP1-p14 scaffolding complex. Structural biology contribution to tyrosine kinase drug discovery. J Mol Biol 379:787–802
Pricl S, Fermeglia M, Ferrone M, Tamborini E (2005) T315I- mutated Bcr-Abl in chronic myeloid leukemia and Imatinib: insights from a computational study. Mol Cancer Ther 4:1167–1174
Acknowledgments
The partial computational work is carried out at Supercomputing facility for bioinformatics and computational biology, Indian Institute of Technology, New Delhi, India, their support is gratefully acknowledged. Special thanks to Prof. B. Jayaram, coordinator SCFbio, Indian Institute of Technology, New Delhi (IITD) to facilitate the access of supercomputer at IITD. Authors are grateful to Dr. Azara Praveen, Zakir Hussain College of Engineering and Technology, Aligarh Muslim University, Aligarh, for proofing the manuscript. KDD thanks to Council for Scientific and Industrial Research (CSIR) for the award of senior research fellowship.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 1172 kb)
Rights and permissions
About this article
Cite this article
Dubey, K.D., Ojha, R.P. Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex. J Mol Model 18, 1679–1689 (2012). https://doi.org/10.1007/s00894-011-1199-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-011-1199-9